KriGen Pharma is a research-oriented company aiming at the development of high quality pharmaceutical products.
Investing more than $ 1 million annually in Research and Development.
Developing 3-5 new generic molecules per year.
Developing 3-5 projects of innovative formulations every year based on Novel Drug Delivery.
With the application of innovative ideas and advanced technologies, KriGen Pharma aims to provide challenging solutions to generic as well as brand dosage form and establish new platform technology with targeted drug delivery.